This content is from: Portfolio Time to Buy, Says GMO Jeremy Grantham’s army is “excited about equity.” By Christine Idzelis March 12, 2020
This content is from: Portfolio GMO: ‘It’s Too Early to Rush’ for Imperiled Credit “Right now it’s bad businesses with bad balance sheets,” a portfolio manager warns. By Amy Whyte May 15, 2020
This content is from: Portfolio GMO Is Feeling Pain Reminiscent of the Late 1990s The patience of GMO’s clients is “wearing thin,” according to Ben Inker, the firm’s head of asset allocation. By Christine Idzelis October 10, 2019
This content is from: Corner Office CircleUp Hires GMO Partner as First CIO in Quant Push The San Francisco firm is bringing quantitative investing to private markets. By Christine Idzelis August 08, 2019
This content is from: Portfolio GMO: Your Portfolio Obsession Is Forcing Bad Calls A simple analysis of historical returns is leading investors to build portfolios that solve the “wrong problem,” according to GMO’s letter to clients. By Christine Idzelis May 09, 2019
This content is from: Portfolio GMO Says Emerging Markets Stocks Will Trounce U.S. Equities The value investing firm is forecasting losses for U.S. stocks over the next seven years. By Christine Idzelis August 22, 2019
